Evidence map›Paper›PMID 36804730›Full record

ArticleBMJ global health2023

The role of community pharmacies in early detection of suspected COVID-19 cases in 2020: lessons from Dar es Salaam, Tanzania.

Hussein Mohamed, Diana Faini, Lusungu Ngailo, Castory Munishi, Rita Mutayoba, Peter Mmbuji, Marcelina Mponela, Leonard Subi, Elias Kwesi, Rose Mpembeni and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Hussein MohamedMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Diana FainiMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of fainidiana@gmail.com.ORCID 0000-0003-3824-8848
Lusungu NgailoAfrican Medical Research Foundation (AMREF) Health Africa, Dar es Salaam, Tanzania, United Republic of.
Castory MunishiMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Rita MutayobaAfrican Medical Research Foundation (AMREF) Health Africa, Dar es Salaam, Tanzania, United Republic of.
Peter MmbujiTanzania Country Office of the U.S Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Marcelina MponelaTanzania Country Office of the U.S Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Leonard SubiMinistry of Health, Dar es Salaam, Tanzania, United Republic of.
Elias KwesiMinistry of Health, Dar es Salaam, Tanzania, United Republic of.
Rose MpembeniMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Mohamed F JallohTanzania Country Office of the U.S Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.ORCID 0000-0002-7206-8042
Wangeci GateiTanzania Country Office of the U.S Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Muhammad BakariMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Janneth MghambaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Muhimbili University of Health and Allied Sciences · TZMinistry of Health and Social Welfare · TZAmref Health Africa · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tanzania reported its first COVID-19 case on 16 March 2020. We conducted event-based surveillance of COVID-19 suspect cases among pharmacy clients presenting with respiratory symptoms and influenza-like illness to increase early and rapid detection of COVID-19 cases and mitigate transmission. We conveniently sampled 103 pharmacies from Dar es Salaam, the epicentre for the COVID-19 pandemic in Tanzania at the time. Between 23 April 2020 and 18 May 2020, 67% of the pharmacies (69/103) reported an observed increase in the number of clients presenting with respiratory symptoms and influenza-like illness compared with the 1 month before the COVID-19 outbreak. In the 1-month surveillance period, the participating pharmacies recorded 75 alerts of COVID-19 suspect cases and referred all suspected COVID-19 cases to rapid response teams for additional symptomatic screening and SARS-CoV-2 testing. A key implementation challenge was that some clients identified as COVID-19 suspected cases were hesitant to provide follow-up information for linkage to rapid response teams. Addressing concerns among drug dispensers in the participating pharmacies and informing them of the benefits of the surveillance activity were important implementation components. Our approach demonstrates the overall feasibility of rapidly implementing an event-based surveillance system for an emerging health threat through an existing network of pharmacies within the community. The approach and tools used in this surveillance activity could be adapted in similar settings to detect and generate alerts of disease outbreaks in the community that other surveillance systems may otherwise miss.

Indexed as

COVID-19Influenza, HumanPharmaciesCOVID-19 TestingHumansPandemicsSARS-CoV-2TanzaniaCOVID-19EpidemiologyHealth policyHealth services researchHealth systems

Identifiers

PMID36804730
PMCPMC9943696
OpenAlexW4321370594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.